Associate Director
Revolution Medicines
Associate Director
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Director, Analytics and Insights, the Associate Director, US Field Analytics, Lung will serve as a key analytics partner to Revolution Medicines’ field organization and Commercial leadership. This role combines strong hands-on analytical capabilities with strategic thinking and business partnership to improve field strategy, deployment, execution, and performance.
The Associate Director will support RevMed field teams broadly, leading analytics and insights across areas including segmentation and targeting, field performance measurement, dashboards and reporting, territory design and alignment, and resource optimization.
The successful candidate will be equally comfortable working directly with complex data and partnering with senior business leaders by translating business questions into clear, actionable recommendations through rigorous analysis.
Field Analytics & Strategy
Lead analytics supporting the design, deployment, and ongoing optimization of RevMed lung-related field teams, including field force sizing and structure, territory design and alignment, resource allocation, and geographic opportunity assessment.
Develop and evolve lung customer and account segmentation, targeting, and prioritization approaches to support effective field engagement.
Own field lung KPIs, performance measurement frameworks, dashboards, scorecards, and reporting, providing leadership with visibility into performance and opportunities at the national, area, region, territory, account, and customer levels.
Conduct advanced and ad hoc analyses to identify business drivers, risks, and opportunities and inform decisions related to field strategy, customer engagement, deployment, and execution.
Support launch readiness and post-launch optimization.
Analytics & Technical Leadership
Serve as a hands-on analytical leader, independently accessing, integrating, analyzing, and interpreting complex commercial datasets using analytics languages (SQL/Python), Excel, and business intelligence tools such as Power BI.
Develop scalable analytical solutions and automate recurring analyses and reporting where appropriate.
Partner with IS teams to define data and analytical requirements and ensure field analytics solutions are accurate, reliable, scalable, and fit for purpose.
Establish and maintain strong standards for field analytics, including metric definitions, methodologies, data quality, documentation, and governance.
Business Partnership & Execution
Serve as a trusted analytics thought partner to field leaders and senior Commercialization stakeholders.
Proactively identify emerging business questions and opportunities.
Partner cross-functionally with Field Leadership, Sales Operations, US Analytics & Insights, Marketing, Omnichannel, IS, and Medical functions.
Drive adoption and effective use of targeting, dashboards, metrics, and analytical tools through ongoing partnership, communication, and training with field teams and leaders.
Manage multiple concurrent initiatives and external analytics partners as needed, delivering high-quality work in a fast-paced and evolving environment.
Required Skills, Experience and Education:
Bachelor’s degree in a quantitative or business-related discipline.
8+ years of progressive experience in commercial analytics, field analytics, sales analytics, commercial operations, or a related function within pharmaceutical, biotechnology, or healthcare organizations.
Demonstrated experience with field strategy and analytics, including segmentation and targeting, territory design/alignment, field performance measurement, dashboards/reporting, and resource optimization.
Experience working with pharmaceutical commercial data, which may include claims, prescription, patient-level, account, distributor, specialty pharmacy, CRM, activity, and other third-party datasets.
Proficient in technical analytics tools, including SQL and/or Python, Excel, and BI tools. Experience with alignment management software, and Veeva CRM preferred.
Demonstrated ability to translate complex analyses into clear, actionable insights and recommendations for senior business leaders.
Strong business acumen, communication, and presentation skills, with demonstrated ability to influence across functions and levels of an organization.
Preferred Skills:
Oncology and/or oral oncolytic product experience.
Experience supporting multiple field functions.
Experience with field force sizing, territory optimization, geographic alignment, or resource allocation methodologies.
Experience developing sophisticated customer/account segmentation and targeting approaches.
Experience supporting commercial analytics from pre-launch through launch and post-launch optimization.
Familiarity with specialty pharmacy, distribution, claims, account, and other oncology-relevant commercial datasets.
#LI-JS1 #LI-Onsite
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 186000 - 233000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines